Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363919950130010077
Journal of the Korean Society for Chemotherapy
1995 Volume.13 No. 1 p.77 ~ p.84
Clinical Effectiveness of Cefminox sodium in the Treatment of Lower Respiratory Tract Infection Superimposed on Chronic Lung Diseases


Kim Young-Sam



Abstract
Cefminox sodium is a new cephamycin antibiotic(7¥á-methoxy-cephalosporin) for injection having a D-cysteine moiety in its 7 -side chain. In addition to the usual action mechanism of ¥â-lactams, for example inhibition of peptidoglycan synthetase by binding to penicillin-binding proteins, cefminox sodium also inhibits cell wall synthesis by binding of lipoprotein in the outer membrane with peptidoglycan. This antibiotic is found to exerta strong and rapid lytic action on sensitive Gram negative bacteria such as E.coli, Klebsiella pneumoniae, Serratia mrcescens and Salmonella enteritidis, and anaerobic bacteria.
We evaluated the effectiveness and the safety of cefminox sodium in 20 patients with lower respiratory tract infection superimposed on moderateoy advanced chronic lung diseases. By monotherapy of cefminox sodium, overall clinical effective rate was 705 and 66.7% of isolated pathogens were eradicated without significant side effect.
KEYWORD
FullTexts / Linksout information
Listed journal information
´ëÇÑÀÇÇÐȸ ȸ¿ø